Viewing Study NCT05279859


Ignite Creation Date: 2025-12-24 @ 2:39 PM
Ignite Modification Date: 2025-12-25 @ 4:28 PM
Study NCT ID: NCT05279859
Status: WITHDRAWN
Last Update Posted: 2022-06-15
First Post: 2022-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies
Sponsor: Erasca, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module